Abdul Waheed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdul Waheed has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Husnain Ahmad
S Tentishev Asian Medical Institute Kant Kyrgyzstan
2 shared publications - Abdul Rehman Shahid Khan
Lahore General Hospital Lahore Punjab Pakistan
1 shared publication - Ahmed Zia
Department of Internal Medicine Punjab Medical College Pakistan
1 shared publication Ali Gohar
Department of Medicine Lahore General Hospital Lahore Pakistan
1 shared publication- Ali Gohar
Department of Pulmonology and Sleep Medicine Lahore General Hospital Lahore Punjab Pakistan
1 shared publication - Aniqa Iqbal
Department of Medicine Lahore General Hospital Lahore Punjab Pakistan
1 shared publication
Latest Publications
- Open Access
- 8 October 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (10) , e73372
Frequency of Metabolic Syndrome in Patients With Hepatitis C Virus Infection: A Cross‐Sectional Study
Background and Aim: Metabolic syndrome significantly increases the risk of cardiovascular disease and type 2 diabetes. Hepatitis C virus (HCV) infection has been associated with an increased risk of metabolic syndrome. This study aims to explore this association to improve management strategies for HCV patients at risk of metabolic syndrome. Methods: A cross‐sectional observational study was conducted in the Department of Medicine, Lahore General Hospital, Lahore, from December 3, 2022, to June 2, 2023. The study employed non‐probability consecutive sampling to include 115 patients diagnosed with HCV infection for at least 6 months. Metabolic syndrome was defined according to the National Cholesterol Education Program Adult Treatment Panel III criteria for Asian‐Americans. Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) version 26.0. Results: Out of 115 individuals with HCV infection, 36 (31.3%) were found to have metabolic syndrome. The condition was slightly more prevalent among males (33.3%) than females (29.3%), although this difference was not statistically significant ( p = 0.642). A higher frequency of metabolic syndrome was observed in participants aged 31–45 years (34.8%) and 46–60 years (32.0%) compared to those aged 15–30 years (21.1%), but this variation was also not significant ( p = 0.549). The duration of HCV infection showed no significant relationship with the presence of metabolic syndrome ( p = 0.386). Multivariable logistic regression further confirmed that gender, age group, and duration of infection were not independently associated with metabolic syndrome. Conclusions: This study indicates that while metabolic syndrome is fairly common among individuals with HCV infection and in older age, its occurrence does not show a significant association with gender, age, or the duration of infection. These results underscore the need for further studies to clarify the complex interplay between HCV and metabolic disturbances.
- 8 October 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (10) , e73372
Open AccessFrequency of Metabolic Syndrome in Patients With Hepatitis C Virus Infection: A Cross‐Sectional Study
Background and Aim: Metabolic syndrome significantly increases the risk of cardiovascular disease and type 2 diabetes. Hepatitis C virus (HCV) infection has been associated with an increased risk of metabolic syndrome. This study aims to explore this association to improve management strategies for HCV patients at risk of metabolic syndrome. Methods: A cross‐sectional observational study was conducted in the Department of Medicine, Lahore General Hospital, Lahore, from December 3, 2022, to June 2, 2023. The study employed non‐probability consecutive sampling to include 115 patients diagnosed with HCV infection for at least 6 months. Metabolic syndrome was defined according to the National Cholesterol Education Program Adult Treatment Panel III criteria for Asian‐Americans. Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) version 26.0. Results: Out of 115 individuals with HCV infection, 36 (31.3%) were found to have metabolic syndrome. The condition was slightly more prevalent among males (33.3%) than females (29.3%), although this difference was not statistically significant ( p = 0.642). A higher frequency of metabolic syndrome was observed in participants aged 31–45 years (34.8%) and 46–60 years (32.0%) compared to those aged 15–30 years (21.1%), but this variation was also not significant ( p = 0.549). The duration of HCV infection showed no significant relationship with the presence of metabolic syndrome ( p = 0.386). Multivariable logistic regression further confirmed that gender, age group, and duration of infection were not independently associated with metabolic syndrome. Conclusions: This study indicates that while metabolic syndrome is fairly common among individuals with HCV infection and in older age, its occurrence does not show a significant association with gender, age, or the duration of infection. These results underscore the need for further studies to clarify the complex interplay between HCV and metabolic disturbances.
- Open Access
- 28 January 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (2)
Heyde Syndrome: A Literature Review
Background and Aims: Heyde syndrome, a triad of anemia from gastrointestinal (GI) bleeding, aortic valve stenosis, and acquired von Willebrand syndrome, primarily affects individuals over 65. Management requires a multidisciplinary approach, including medical therapy, endoscopic intervention, and valve replacement. Despite advances, many aspects remain unclear. This review explores the epidemiology, pathophysiology, and management of Heyde syndrome while highlighting areas for future research. Methods: A comprehensive search of PubMed and Google Scholar focused on English‐language human studies, including case reports, clinical trials, reviews, and expert guidelines. Additional literature on Von Willebrand syndrome and GI angiodysplasia was reviewed. The final search was completed on April 5, 2025. Results: Aortic valve replacement improves outcomes and hematologic abnormalities. Transcatheter aortic valve replacement (TAVR) showed lower rates of life‐threatening bleeding, fewer perioperative complications, and reduced transfusions compared to surgical replacement. Guidelines recommend dual antiplatelet therapy (DAPT) for 3–6 months post‐TAVR, with 79%–86% of patients experiencing no recurrence of GI bleeds. Management of intestinal angiodysplasia often shows high recurrence rates due to persistent lesions and vWS‐2A. Surgical valve replacement also improves bleeding control, even with anticoagulation. Aortic valve replacement should be first‐line therapy in severe aortic stenosis with chronic GI bleeding. Conclusion: Heyde syndrome remains a complex and often underrecognized condition in elderly populations. Continued research is critical to deepen understanding and improve patient outcomes, allowing for more personalized and effective care strategies.
- 28 January 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (2)
Open AccessHeyde Syndrome: A Literature Review
Background and Aims: Heyde syndrome, a triad of anemia from gastrointestinal (GI) bleeding, aortic valve stenosis, and acquired von Willebrand syndrome, primarily affects individuals over 65. Management requires a multidisciplinary approach, including medical therapy, endoscopic intervention, and valve replacement. Despite advances, many aspects remain unclear. This review explores the epidemiology, pathophysiology, and management of Heyde syndrome while highlighting areas for future research. Methods: A comprehensive search of PubMed and Google Scholar focused on English‐language human studies, including case reports, clinical trials, reviews, and expert guidelines. Additional literature on Von Willebrand syndrome and GI angiodysplasia was reviewed. The final search was completed on April 5, 2025. Results: Aortic valve replacement improves outcomes and hematologic abnormalities. Transcatheter aortic valve replacement (TAVR) showed lower rates of life‐threatening bleeding, fewer perioperative complications, and reduced transfusions compared to surgical replacement. Guidelines recommend dual antiplatelet therapy (DAPT) for 3–6 months post‐TAVR, with 79%–86% of patients experiencing no recurrence of GI bleeds. Management of intestinal angiodysplasia often shows high recurrence rates due to persistent lesions and vWS‐2A. Surgical valve replacement also improves bleeding control, even with anticoagulation. Aortic valve replacement should be first‐line therapy in severe aortic stenosis with chronic GI bleeding. Conclusion: Heyde syndrome remains a complex and often underrecognized condition in elderly populations. Continued research is critical to deepen understanding and improve patient outcomes, allowing for more personalized and effective care strategies.